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Abstract
Background. Studying offspring of schizophrenia (SZo) and bipolar disorder patients (BDo)
provides important information on the putative neurodevelopmental trajectories underlying
development toward severe mental illnesses. We compared intracranial volume (ICV), as a
marker for neurodevelopment, and global and local brain measures between SZo or BDo and
control offspring (Co) in relation to IQ and psychopathology.
Methods. T1-weighted magnetic resonance imaging (MRI) brain scans were obtained from
146 participants (8–19 years; 40 SZo, 66 BDo, 40 Co). Linear mixed models were applied to
compare ICV, global, and local brain measures between groups. To investigate the effect of ICV,
IQ (four subtestsWechsler Intelligence Scale for Children/Wechsler Adult Intelligence Scale-III)
or presence of psychopathology these variables were each added to the model.
Results. SZo and BDo had significantly lower IQ and more often met criteria for a lifetime
psychiatric disorder than Co. ICV was significantly smaller in SZo than in BDo (d=0.56) and
Co (d=0.59), which was largely independent of IQ (respectively, d=0.54 and d=0.35).
After ICV correction, the cortex was significantly thinner in SZo than in BDo (d=0.42) and Co
(d=0.75) and lateral ventricles were larger in BDo than in Co (d=0.55). Correction for IQ or
lifetime psychiatric diagnosis did not change these findings.
Conclusions.Despite sharing a lower IQ and a higher prevalence of psychiatric disorders, brain
abnormalities in BDo appear less pronounced (but are not absent) than in SZo. Lower ICV in
SZo implies that familial risk for schizophrenia has a stronger association with stunted early
brain development than familial risk for bipolar disorder.
Introduction
Offspring of parents with severe mental illnesses (SMI), such as schizophrenia (SZ) and bipolar
disorder (BD), have a more than 10-fold increased risk to develop a psychotic disorder or BD and
a twofold to threefold increased risk to develop any lifetime DSM-IV axis-I disorder compared
to offspring of parents without these diagnoses [1]. Importantly, in contrast to adult relatives of
patients with SMI, adolescent offspring are below the usual age of onset, that is, young
adulthood. Moreover, offspring are often (still) unmedicated, even when (subtle) symptoms
are present. Consequently, the intake of psychotropic medication does not influence the
clinical, cognitive, and neural measures and does not confound differences between individuals
with and without specific symptoms or diagnoses. It has also been suggested that SMI may be a
result of (early) neurodevelopmental abnormalities [2,3]. Thus, adolescent offspring of patients
with SZ (SZo) and BD (BDo) provide a unique population to investigate putative neurodeve-
lopmental trajectories toward these disorders.
Intracranial volume (ICV) may be considered a neurodevelopmental marker in early life and
possibly early adolescence. Around the age of 5, ICV has reached 90% of its full size, implying that
the size of the cranium is mostly determined by the growth of the brain during these early years
[4,5]. Another spurt occurs between 10 and 15years of age [4]. Moreover, the adolescent brain
undergoes significant structural and functional development, creating a sensitive window for
psychiatric symptoms [6], whichmakes adolescence a particularly interesting timewindow to study.
Interestingly, a smaller ICV relative to controls is consistently found in adult patients with SZ,
but not in patients with BD [7–10]. Investigating ICV in SZo and BDo may shed light on the
disease-specific neurodevelopmental nature of SMI that emerge later in life.
In addition to ICV, global and local cortical brain measures show abnormalities in SZ and BD
patients [7–10], with usually lower effect sizes in BD patients. A recent meta-analysis comparing
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first-degree relatives to controls (which included the current sam-
ple; [11]) reported larger ICV in BD relatives and no difference in
SZ relatives. Interestingly, smaller global brain volumes were found
after correction for ICV in SZ relatives, but not in BD relatives.
However, De Zwarte et al. [11] did not correct for the possible
confounding effect of IQ, which is considered an indication of
aberrant neurodevelopment preceding the onset of SMI, in partic-
ular for SZ [12]. A lower premorbid IQ is found in SZ patients,
while premorbid IQ appears to be higher in BD patients [13],
although findings are inconsistent [14,15]. Moreover, the presence
of (subclinical) psychopathology during adolescence is a well-
established premorbid indicator of risk for SMI later in life. Both
IQ and psychopathology have been found to be associated with ICV
and global and local brain measures in SZ and BD [9,11,13,16–23].
The aim of the current study is threefold. First, we compare ICV,
IQ, and presence of psychopathology among SZo, BDo, and control
offspring (Co) to investigate whether we can identify evidence for
abnormal neurodevelopment in SZo and/or BDo. As findings of
smaller ICV are more consistently found in SZ than in BD patients
[7–10] and findings that lower IQ increases risk for SZ are more
consistently found than for BD [12], we hypothesize that ICV is
smaller and IQ is lower in SZ, but not in BDo, as compared to Co. In
line with previous studies [1], we expect that presence of psychopa-
thology is increased in SZo and BDo compared to Co. Second, we
compare global (i.e., total brain, gray matter [GM], white matter
[WM], and cerebellar volumes, mean cortical thickness and mean
surface area) and local (i.e., subcortical and cortical Region of Interest
[ROI] volumes) brain measures between groups, with and without
ICV correction. Based on previous offspring studies [24–34], we
expect that brain abnormalities are more pronounced in SZo than
in BDo relative to Co. Finally, we investigate whether IQ or presence
of psychopathology explains potential differences between groups in
global and local structural brain measures. Both may explain some
variation in brain abnormality differences between the groups; how-
ever, in line with a recent meta-analysis [11], we hypothesize that
smaller brain measures will be significantly related to familial risk.
Methods
Participants
A total of 146 children and adolescents participated between 2010
and 2015 in the Dutch Bipolar and Schizophrenia Offspring study
at baseline, that is, 40 SZo (8.9–18.9 years), 66 BDo (9.1–19.8 years),
and 40 Co (8.2–17.2 years). Brain imaging, genetic, cognitive, psy-
chological, and environmental data were collected on several visits
in the University Medical Center Utrecht (UMCU). Co were
recruited via advertisement on schools or leisure clubs (57.5%),
or via hospital staff (42.5%). SZo and BDo were recruited via their
psychiatrist from the UMCU or other mental health care centers in
the Netherlands (28.3%), their parent’s or sibling’s psychiatrist
(37.7%), or through advertisement (34%; e.g., lectures, patient
advocacy groups and study website). Inclusion criteria were off-
spring who were Dutch speaking and specifically for the at-risk
offspring, at least one first- or two second-degree family members
(with the vast majority being offspring). Exclusion criteria were
severe physical illness, handicap, neurological problems (e.g., open-
or closed head injury, epilepsy) or IQ<70, and specifically for Co, a
first-degree relative with a severe mood or psychotic disorder. Co
were not excluded in case one of the parents has had a single mild
depressive episode during young adulthood to prevent the inclu-
sion of a super healthy population.
Recruitment of particularly SZo is difficult, thus groups were not
matched on age, sex, and IQ. Groups were matched on parental
level of education.
Written informed consent was obtained from offspring older
than 12 years, and both parents or legal caregivers for the partici-
pation of offspring aged 8–18 years. Parents also gave written
consent for their own participation. TheMedical Ethics Committee
of the UMCU approved the study.
MRI acquisition
Magnetic Resonance Imaging (MRI) brain scans were obtained on a
Philips 3-Tesla Achieva scanner (Philips Medical Systems, Best, the
Netherlands), located at the UMCU. A three-dimensional
T1-weighted sagittal spoiled-gradient fast-field echo scan of the
whole brain (with 200 contiguous slices; 0.75mm 0.75mm 0.8
mm voxels, TE=4.6ms, TR=10ms, flip angle = 8°, field of view=
240mm) was acquired. All images were coded to ensure blinding for
participant identification and diagnoses during image processing.
Image processing
The automated segmentation procedure of FreeSurfer software
package version 5.3.0 (http://surfer.nmr.mgh.harvard.edu/) was
used for subcortical and cortical volume, cortical thickness, and
cortical surface area estimations. See the supplementary text for a
detailed description of the processing procedure. After image pro-
cessing, a quality check for volume, thickness, and surface labeling
was performed according to the ENIGMA criteria (http://enigma.
ini.usc.edu/). Manual corrections were made in case of poor GM,
WM, or cerebral spinal fluid differentiation. Fifteen images (NCo =
3, NBDo= 11, and NSZo = 1) with poor quality of ROI labeling were
excluded from the analyses, resulting in 40 Co, 66 BDo, and 40 SZo.
Instruments
All psychiatric and neuropsychological assessments were con-
ducted by trained interviewers with a bachelor’s or master’s level
degree in medicine or psychology, supervised by a psychiatrist
certified in adult, and child and adolescent psychiatry (M.H.J.H.).
Parents
Index parents (i.e., the parent with SZ or BD) received a Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I; [35]) to
confirm their DSM-IV [36] axis I diagnoses. Co-parents and control
parents were screened for lifetime psychopathology with the mini-
Schedule for Clinical Assessment inNeuropsychiatry (mini-SCAN)
interview [37], followed by a SCID-I in case of reported psychopa-
thology.
Offspring
Offspring received the Schedule for Affective Disorders and Schizo-
phrenia for School Age Children Present and Lifetime Version
(K-SADS-PL; [38]), which is a face-to-face semi-structured interview.
The interview was administered to participants and their parents
separately and summary information was used to establish lifetime
DSM-IV axis I diagnoses. Autism spectrum diagnoses were based on
psychiatric evaluations from the outpatient clinic or referring psychi-
atrist. In addition, autism spectrum symptomswere evaluatedwith an
additional supplement to the K-SADS-PL according to the DSM-5.
IQ was estimated based on the subtests Picture Arrangement,
Block Design, Vocabulary, and Information from the Wechsler
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Intelligence Scale for Children-III [39] for participants younger
than 17 years old orWechsler Adult Intelligence Scale-III [40] from
the age of 17.
Statistics
Demographic variables
Between-group comparisons were done with one-way ANOVAs
for continuous variables, and Pearson chi-square tests for categor-
ical variables. Post hoc, pairwise group comparisons were done in
case of significant main effects of group.
Aim 1: ICV, IQ, and psychopathology
IQ and ICV were compared between groups using linear mixed-
effects models with group as fixed effect (α= 0.05). As we included
more than one offspring per family, family membership was added
as random effect to account for similarities within families. Age and
sex were added as covariates when comparing ICV between groups
and analyses were repeated on subsets that were matched for age
and sex. Post hoc, pairwise group comparisons were performed and
Cohen’s d effect sizes were calculated. The lifetime prevalence of
psychopathology based on the K-SADS-PL was compared between
groups using Pearson chi-square tests (α=0.05) and post hoc,
pairwise group comparisons were done in case of significant main
effects of group.
Aim 2: Group differences on global and local brain measures
Linear mixed-effects models were performed on brain measures,
adding age, sex, and ICV as covariates (ICV was left out for mean/
local cortical thickness and mean/local surface area). Local ROI
volumes from the left and right hemisphere were summed to reduce
the number of tests.
The significance level for the main effect of group for global
brain volume analyses was set at α=0.05. For subcortical volumes
(n=7) and cortical ROIs (n= 34), FDR correction for multiple
testing was applied (α=0.05; [41]). Post hoc pairwise comparisons
are reported at an uncorrected α< 0.05 and effect sizes are reported.
Aim 3: Effect of psychopathology and IQ on ICV
Pearson correlations were calculated of IQ with ICV and whole
brain volume in the total sample and in each group. Correlations
were compared with Fisher-r-to-z transformation. IQ and the
presence of psychiatric diagnosis (yes/no) were each added as an
additional covariate in separate linear mixed models to investigate
their effect on the group differences in brain measures.
Analyses were repeated, excluding subjects on medication
(NBDo = 4, NSZo = 7). Analyses were conducted using Statistical
Package for Social Sciences, version 23.0 (SPSS for Windows,
IBM Corp, 2015) and R (https://www.R-project.org).
Results
Aim 1: ICV, IQ, and psychopathology
Table 1 provides an overview of the demographic and clinical
characteristics of the groups. There was no significant difference
between SZo and BDo in age, but BDo were significantly older than
Co. In addition, there were significantly more females among SZo
as compared to BDo.
A significant main effect of group was found for ICV. Pairwise
comparisons revealed significantly smaller ICV in SZo than in BDo
(d=0.56) and Co (d=0.59; Table 2/Figure 1). To match the
subgroups on age, we excluded the 12 oldest BDo. This resulted in
similar findings. To check if the smaller ICV in SZo was not
explained by the lowest volumes, the analyses were repeated with-
out three participants (all girls). Again, this resulted in similar
findings (Table S4).
IQwas significantly lower in SZo (d=1.06) andBDo (d=0.67)
as compared with Co. Although IQ was lower in SZo than in BDo, it
did not differ significantly (d=0.34).
SZo and BDo more often met criteria for a lifetime psychiatric
disorder than Co. The frequency did not differ significantly
between SZo and BDo. The types of psychopathology are presented
in Table 1. No significant differences on age, sex, and IQwere found
between those with and without a diagnosis (Table S1).
Aim 2: Group differences on global and local brain measures
Table 2 shows group differences in global brainmeasures, corrected
for age, sex, and ICV. The cortex was significantly thinner in SZo
than in BDo (d=0.42) and Co (d=0.75) and lateral ventricle
volume was significantly larger in BDo than in Co (d=0.55).
Surprisingly, the effect size of the SZo–Co comparison of lateral
ventricle volume (d=0.56) was comparable to that of the BDo–Co
comparison; however, the first did not reach significance (p=0.09)
while the latter did. Therefore, we cannot rule out that the enlarge-
ment in lateral ventricle volume is not specific to BDo. Effect sizes of
pairwise comparisons of global brain measures among SZo, BDo,
and Co are presented in Figure 2. Subcortical and local cortical
volumes were not significantly different between groups after cor-
rection for age, sex, and ICV (Table S2).
Aim 3: Effect of psychopathology and IQ on ICV
ICV and whole brain (WB) volume correlated significantly with
IQ across all subjects (rICV-IQ = 0.37, p= 0.7 105 and rWB-IQ =
0.47, p= 0.4 108) and correlations were comparable between
groups, albeit non-significant in Co for ICV (ICV-IQ: rSZo = 0.32,
p= 0.05; rBDo = 0.41, p= 0.001; rCo = 0.21, p= 0.20; WB-IQ: rSZo =
0.53, p < .001; rBDo = 0.39, p= 0.002; rCo = 0.34, p = 0.03). Using
Fisher r-to-z transformation, pairwise differences between these
correlations were not significant (all p > 0.21).
After IQ correction, the main effect of group on ICV remained
trend-level significant (p= 0.05). Pairwise comparisons showed
that ICV remained smaller in SZo compared to BDo with a com-
parable effect size (d=0.54); however, the difference between SZo
and Co was no longer significant and had a moderately smaller
effect size (d=0.35; Table S3).
After correction for the presence of a psychiatric diagnosis, the
main effect of group on ICV remained significant (p= 0.03) and
pairwise analyses showed that ICV is smaller in SZo compared to
Co (d=0.60) and BDo (d=0.56). The findings in the global and
local brain measures after correction for IQ or presence of a
psychiatric diagnosis remained similar (Table S3).
Finally, repeating the main analyses without the 11 offspring
who used psychotropic medication did not change the pattern of
findings (results are available upon request).
Discussion
The current study aimed to investigate whether early neurodeve-
lopment, as expressed by ICV, is differentially affected in young SZo
and BDo. Our main finding is that SZo had a significantly smaller
ICV than BDo and Co. This corresponds with the smaller ICV
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Table 1. Offspring demographics, psychopathology and medication use, parental diagnoses, and parental education in schizophrenia offspring (SZo), bipolar offspring (BDo), and control offspring (Co)
Offspring characteristics SZo (N = 40) BDo (N = 66) Co (N = 40) Main effect
Pairwise
SZo vs. BDo SZo vs. Co BDo vs. Co
p p p p
Families N = 30 N = 48 N = 30
Sex m/f (% female) 12/28 (70%) 37/29 (44%) 21/19 (48%) X2 = 7.24 0.03 0.01 (SZo >BDo) 0.04 (SZo >Co) 0.72
Age M (SD) 13.77 (2.97) 14.52 (2.67) 12.74 (2.14) F = 6.36 0.002 0.31 0.17 0.001 (BDo>Co)
IQ M (SD)a 100.58 (19.17) 106.67 (18.30) 117.05 (13) F = 9.11 0.001 0.10
d = 0.34
<0.001 (SZo <Co)
d =1.06
0.004 (BDo<Co)
d = 0.67
Offspring lifetime axis I diagnoses n (%)b SZo (N = 40) BDo (N = 62) Co (N = 39)
Any diagnosis 22 (55%) 28 (45.2%) 7 (17.9%) X2 = 12.29 0.002 0.33 0.001 (SZo >Co) 0.01 (BDo>Co)
Any mood diagnosis 7 (17.5%) 17 (27.4%) 4 (10.3%) X2 = 4.63 0.10
Major depression disorder 5 (12.5%) 1 (1.6%) 0 X2 = 9.47 0.01 0.02 (SZo >BDo) 0.02 (SZo >Co) 0.43
Anxiety disorder 5 (12.5%) 4 (6.5%) 1 (2.6%) X2 = 3.03 0.22
ADHD 2 (5%) 1 (1.6%) 0 X2 = 2.51 0.29
PDD/Asperger 5 (12.5%) 3 (4.8%) 0 X2 = 5.91 0.05
Other disorders 3 (7.5%) 3 (4.8%) 2 (5.1%) X2 = 0.35 0.84
Medication use total sample (n)
Antipsychotics 1 1 n.a.
SSRI 1 1 n.a.
Stimulants 4 1 n.a.
Antipsychotics + SSRI 1 0 n.a.
Stimulants + SSRI 0 1 n.a.
Diagnosis index parent n
Bipolar I disorder n.a. 39 n.a.
Bipolar II disorder n.a. 8 n.a.
Bipolar NOS 1
Schizophrenia 19 n.a. n.a.
Schizoaffective disorder 7 n.a. n.a.
Psychosis NOS 4 n.a. n.a.
Highest level of parental education (% secondary/continued education) 38.7/61.3 28.6/71.4 19.4/80.6 X2 = 3.04 0.22
Abbreviations: ADHD, attention deficit hyperactivity disorder; BDo, bipolar disorder offspring; Co, control offspring;M, mean; n.a., not applicable; NOS, not otherwise specified; PDD, pervasive developmental disorder; SD, standard deviation; SSRI, selective
serotonin reuptake inhibitor; SZo, schizophrenia offspring.
“Any mood diagnosis” also comprises major mood disorder; “other disorders” comprise eating disorder not otherwise specified, tic disorder, adjustment disorder with mixed disturbances of emotions and conduct, elimination disorder, and substance
abuse disorder.
aIQ is missing in three BDo.
bFor five participants, the administration of the interview did not coincide with the MRI scan date.
The significance level was set at α = 0.05.
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Table 2. Global brain volumes in schizophrenia offspring (SZo), bipolar offspring (BDo), and control offspring, corrected for age, sex, and intracranial volume
Pairwise
Global brain
volumes
SZo (N = 40) BDo (N = 66) Co (N = 40) Main effect SZo <Co BDo <Co SZo <BDo
M (SD) M (SD) M (SD) F (df, df ) p p d (CI 95%) p d (CI 95%) p d (CI 95%)
Effect of group (corrected for age and sex)
Intracranial (cm3)a 1,446 (200) 1,589 (183) 1,566 (161) 4.21 (2,107.8) 0.017 0.015 0.59 (1.03, 0.14) 0.917 (BDo>Co) 0.03 (0.42, 0.37) 0.010 0.56 (0.96,
0.16)
Cortical thickness
(mm)a
2.6 (0.1) 2.6 (0.1) 2.7 (0.1) 4.67 (2,108.5) 0.011 0.003 0.75 (1.21, 0.3) 0.207 0.28 (0.67, 0.12) 0.042 0.42 (0.82,
0.03)
Cortical surface
area (cm2)a
875 (98) 930 (93) 930 (84) 2.31 (2,108.8) 0.104 0.036 0.52 (0.96, 0.07) 0.384 0.21 (0.6, 0.19) 0.147 0.32 (0.71,
0.08)
Effect of group (corrected for age, sex, and intracranial volume)
Total brain (cm3) 1,127 (128) 1,208 (116) 1,225 (108) 2.74 (2,110.4) 0.069 0.067 0.48 (0.93, 0.04) 0.029 0.53 (0.93,0.13) 0.891 0.03 (0.36,
0.42)
Cortical GM (cm3) 526 (69) 560 (54) 578 (48) 2.18 (2,106.7) 0.118 0.051 0.54 (0.98, 0.09) 0.101 0.38 (0.78, 0.01) 0.588 0.11 (0.51,
0.28)
Subcortical GM
(cm3)
63 (5) 67 (6) 67 (5) 1.24 (2,109.1) 0.293 0.124 0.39 (0.84, 0.05) 0.280 0.24 (0.63, 0.16) 0.525 0.16 (0.55,
0.23)
Cortical WM (cm3) 411 (53) 448 (60) 444 (54) 2.13 (2,112.6) 0.123 0.354 0.26 (0.7, 0.18) 0.042 (BDo>Co) 0.46 (0.86,0.06) 0.319 0.22 (0.17,
0.62)
Lateral ventricles
(cm3)
11.6 (6.4) 15.6 (10.5) 11.3 (4) 3.55 (2,101.6) 0.032 0.090
(SZo >Co)
0.56 (0.12, 1.01) 0.009 (BDo >Co) 0.55 (0.15, 0.95) 0.469 0.15 (0.54,
0.24)
Third ventricle (cm3) 0.8 (0.2) 0.8 (0.2) 07. (0.2) 2.32 (2,101.5) 0.104 0.039
(SZo >Co)
0.53 (0.09, 0.98) 0.480 (BDo>Co) 0.16 (0.23, 0.56) 0.111
(SZo >BDo)
0.37 (0.03,
0.76)
Cerebellum (cm3) 100 (13) 106 (10) 107 (11) 0.25 (2,109.1) 0.778 0.502 0.15 (0.59, 0.29) 0.858 0.04 (0.44, 0.35) 0.572 0.13 (0.53,
0.26)
Analyses are performed in a mixed model with correction for family membership.
Abbreviations: BDo, bipolar disorder offspring; Co, control offspring; d, Cohen’s d; df, degree of freedom; GM, gray matter; M, mean; SD, standard deviation; SZo, schizophrenia offspring; WM, white matter.
aStatistics for intracranial volume, mean cortical thickness and mean cortical surface area are not corrected for intracranial volume.
The significance level was set at α = 0.05. FDR correction for multiple testing was applied for subcortical volumes and ROIs.
found in adult SZ patients, but not in BD patients, compared to
controls [9]. Thus far, studies on ICV of SZo and BDo are sparse
and findings are inconsistent [27,29,42]. Sugranyes et al. [42]
showed no significant differences in ICV between SZo (n=38),
BDo (n=77), and Co (n=83), aged 6–17 years. Other studies,
focusing on one disorder, reported decreased ICV in SZo (n=17)
compared to Co (n=22), aged 9–22 years [29] and no significant
differences between BDo (n=26) and Co (n= 31), aged 15–30 years
[27]. These and our findings suggest that a smaller ICV may be
specific for SZo. The question remains, at what critical stage during
development the ICV stays behind in SZo. It has been reported that
the first 5 years of life are characterized by rapid linear growth of
ICV, with another spurt between 10 and 15 years of age [4]. Addi-
tionally, head circumference (i.e., a proxy for ICV) was smaller in
babies who later developed SZ [43,44]. Further evidence suggests a
lower height at age two in children who later developed a non-
affective psychotic disorder [45]. These studies suggest that prena-
tal risk factors or diminished growth during the first 5 years may
explain our finding of a smaller ICV in child and adolescent SZo.
Whether SZo and BDo differ in ICV-growth during adolescence
remains unclear. Longitudinal studies in large samples including
children and adolescents between 8 and 20 years old are needed to
address this question.
Importantly, IQ was significantly lower and the prevalence of
psychiatric disorders was significantly higher in both SZo and BDo
as compared to Co. With respect to SZ, level of IQ has also been
considered an indirect indication of aberrant neurodevelopment, as
IQ-scores are below those of healthy subjects, years before diagnosis
[46–51]. In contrast, recent evidence suggests that aU-shaped effect
explains the relationship between IQ and risk for BD, with an even
higher risk for above-average cognitive performance than low IQ
[52,53]. However, in our cohort, both SZo and BDo had a lower IQ
than controls. Moreover, we found no differences in IQ between
offspring with and without a DSM-IV diagnosis.
The lower IQ and higher burden of psychopathology did not
fully explain the smaller ICV in SZo. After IQ correction, ICV was
still smaller in SZo than in BDo with a similar effect size, but the
difference between SZo and Co was no longer significant. Correct-
ing for the presence of a psychiatric diagnosis did not affect the ICV
findings. This suggests that it is not the presence of psychopathol-
ogy, but the increased familial risk for SZ that influences brain
development in early life leading to a smaller ICV. Taken together,
our finding of a smaller ICV in SZo than in BDo provides evidence
for aberrant (possibly early) brain development in relation to SZ
risk, which is in line with the neurodevelopmental model of SZ
[54,55]. Future studies with larger samples may have increased
statistical power to address the possible differential associations
between IQ and ICV with familial risk for SZ or BD.
In addition to ICV, we compared the groups on other brain
measures after correcting for ICV.We found a significantly thinner
cortex in SZo than in BDo and Co and larger lateral ventricle
volume in BDo than in Co. The SZo-Co comparison of lateral
ventricle volume was not statistically significant, despite a compa-
rable effect size. The absence of significant differences in local
cortical ROI volumes suggests that brain abnormalities in relation
to increased familial risk for BDor SZ representmostly a global, and
not a local effect. Alternatively, the sample size may have been too
small to identify subtle local abnormalities in SZo and BDo.
Figure 1. Estimated intracranial volume in SZo, BDo, and Co after correction for age and sex. Abbreviations: BDo, bipolar disorder offspring; Co, control offspring; SZo,
schizophrenia offspring. SZo <BDo, p = 0.010; SZo <Co, p = 0.015.
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Whether local brain abnormalities play a role in the prediction of
future illness onset remains to be elucidated when longitudinal data
become available.
Our local brain imaging findings differ from those of a Spanish
SZo/BDo cohort, who reported smaller local volumes in the left
inferior frontal gyrus/anterior insula in SZo relative to both BDo
and Co. In addition, they did not find a significant difference in
ICV, but found a smaller surface area in SZo than in BDo and Co
[42,56]. ICV and surface area are usually highly correlated [57],
suggesting that the smaller ICV in our study and the smaller surface
area in the Spanish cohort in SZomay represent the same underlying
process. Other offspring studies reported smaller volumes of the
whole brain, frontal and temporal lobes, corpus callosum, and sub-
cortical structures in SZo compared to Co, while brain abnormalities
in BDo are less conclusive [25–29,31–34,58]. Taken together, brain
abnormalities appear more pronounced in SZo compared to BDo.
Despite our relatively large sample size and the inclusion of both
SZo and BDo at one site (with one scanner), some limitations have to
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Figure 2. Effect sizes of pairwise comparison among SZo, BDo, and Co of global brain measures. (A) Corrected for age, sex, and ICV; (B) corrected for age, sex, ICV, and IQ; and
(C) corrected for age, sex, ICV, and diagnosis. Abbreviations: BDo, bipolar disorder offspring; Co, control offspring; GM, gray matter; ICV, intracranial volume; SZo, schizophrenia
offspring; WM, white matter.
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be considered. SZo were more often referred by their treating psy-
chiatrist than BDo, who were more often referred by the parent’s
physician. It is possible that this may have resulted in more severe
levels of psychopathology in SZo and we cannot rule out that this
influenced our results. In addition, controls had a rather high level of
IQ, although our groupswerematched onparental education. Finally,
the current study presents cross-sectional data, which does not allow
to differentiate between deficits in neurodevelopment and a delay in
neurodevelopment. However, when longitudinal data becomes avail-
able, it will be possible to investigate the neurodevelopmental trajec-
tories toward specific disorders, taking into account other early
developmental and environmental factors (e.g., circumstances of
gestation, birth and upbringing, and cumulative life events).
To conclude, the familial risk for SZ may be related to stunted
brain development early in life, which is less for BD. Irrespective of
a lower IQ and increased presence of psychopathology in SZo and
BDo, abnormal early neurodevelopment (expressed by a smaller
ICV) differentiated SZo from BDo and Co. In addition, the cortex
was thinner in SZo and lateral ventricles were larger in BDo (and
possibly also in SZo), confirming that brain abnormalities appear
more pronounced in SZo than in BDo. The lack of local brain
volume abnormalities in the familial high-risk groups may suggest
that brain abnormalities related to the risk to develop SMI are
related to processes that affect global brain measures, but larger
samples are needed to confirm this.
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